#VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
1. In this randomized controlled trial, among patients with recurrent kidney stones, hydrochlorothiazide did not alter the risk of symptomatic or radiographic stone recurrence. 2. Hydrochlorothiazide was associated with an increased risk of adverse events as compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Kidney stones are a common medical condition. In many patients, these